This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Glaxo acquires Wellcome in $14 billion hostile bid
13 Jul 1999
In a surprise takeover offer, Glaxo has offered Wellcome shareholders $14.15 billion, or $16.20 (UK10.25) per share or ADS (a 49% premium to Wellcome's recent closing price of about $10.75) in cash and stock. Update: deal finalized.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?